US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.
The market research available can provide investors and analysts credible information on the direction of pharmaceuticals, anesthesia, drug delivery, pricing, regulations and policy being developed to ensure that knowledgeable and informed decisions are made regarding industry direction.
  • Biopharmaceuticals (233)
  • Diseases & Conditions (4577)
  • Drug Delivery (190)
  • Therapeutic Area (7218)
  • Vaccines (655)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
6/19/2015 | published by: Kalorama Information
... in developing more effective cancer therapeutics. Besides the research applications, the detection and analysis of CTCs has enormous potential in the diagnosis and management of cancer, as current tools, such as tumor tissue biopsy or ...  |  read more...
USD 4,200
Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2015
7/1/2015 | published by: DelveInsight
... active CAR-T cell products in research and development. The Report covers the 35+ companies which are active in this field including 14 leading companies with 35 products targeting 20 different antigens and 9 different technologies. ...  |  read more...
USD 1,750
Analgesics in Australia
6/15/2015 | published by: Euromonitor International
... needs such as pain relief. The retail current value growth of 4% in 2014 was similar to the growth the previous year. Euromonitor International's Analgesics in Australia report offers a comprehensive guide to the size ...  |  read more...
USD 990
Scientific Research and Development (R&D) Industry, in Physics, Engineering, Life Sciences, Drugs, Telecommunications and Electronics Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2022, NAIC 541710
6/29/2015 | published by: Plunkett Research, Ltd.
... benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Scientific Research and Development (R&D) Industry, in Physics, Engineering, Life Sciences, Drugs, Telecommunications and Electronics Industry (U.S.) to reach ...  |  read more...
USD 1,995
Belarus Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... to behurt by these factors. We expect the Belarusian government to increase its focus on import substitutiongiven its balance of payments crisis, with negative implications for the pharmaceutical sector. Headline Expenditure Projections Pharmaceuticals: BYR10,223bn in ...  |  read more...
USD 1,295
Czech Republic Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... Exports are to see a rise in demand from tradingpartners based on our expectation of increasing generic penetration throughout Europe and demand forgenerics in general across emerging markets. We expect imports to be boosted by ...  |  read more...
USD 1,295
India Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... is driven by the low levels ofhealthcare funding provided by the government as it seeks to reduce budget deficit and prioritise othersectors such as infrastructure. Moreover, we highlight that improvements in healthcare access from theprogramme ...  |  read more...
USD 1,295
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... abroad. Over the long-term, domesticmanufacturers will increase their market share, with the government placing an increasing emphasis onachieving self-sufficiency in terms of pharmaceutical production. Headline Expenditure Projections Pharmaceuticals: SDG2.35bn (USD402mn) in 2014 to SDG2.65bn (USD433mn) ...  |  read more...
USD 1,295
United Kingdom Pharmaceuticals and Healthcare Report Q3 2015
6/10/2015 | published by: BMI Research
... spending, for future business expansion potentialsto be met there needs to be a focus upon evolving current healthcare services while also containing costs. On a pharmaceutical front, this evolution needs to take place through the ...  |  read more...
USD 1,295
China Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... access through stronger medicalsubsidies and an expansion of insurance coverage. In addition, reforms in the pharmaceutical sector,including the removal of price caps, will shift the industry towards a market-based system that furtheraugments the commercial prospects. ...  |  read more...
USD 1,295
Cuba Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... cooperation with the island's pharmaceutical sector andJapanese investment in Cuba's healthcare system underscore the significant progress Cuba has achieved inrecent years. Therefore, Cuba will continue to offer unique commercial opportunities to foreign companieswho will benefit ...  |  read more...
USD 1,295
Ireland Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... fundamentals and Ireland's government policies to attractforeign investment in the pharmaceutical sector. Recent acquisitive trends are illustrated by ongoingmerger bids between Mylan, Perrigo and Teva, as well as Actavis' acquisition of Allergan, of which theoutcome ...  |  read more...
USD 1,295
Moldova Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... and GBP combined with the full force of Western sanctions against the Russian Economy,as well as the drop in global oil prices. Indeed, a sluggish road is ahead for market growth in Moldova. However, increased ...  |  read more...
USD 1,295
Morocco Pharmaceuticals and Healthcare Report Q3 2015
6/17/2015 | published by: BMI Research
... innovative drugmakers to continueseeking opportunities in Morocco, particularly with recent updates to the intellectual property law thathighlights the country's commitment to improving the operating environment for multinationals. Headline Expenditure Projections Pharmaceuticals: MAD12.12bn (USD1.44bn) in 2014 ...  |  read more...
USD 1,295
Blood Glucose Meter: Technology, Business Opportunity and Patent Analysis
6/15/2015 | published by: Market Intelligence & Consulting Institute
... high sugar and calorie intakes. Having a blood glucose meter is evidenced to help diabetes patients effectively control blood glucose levels, thereby reducing the risk of complications associated with diabetes. This report provides an overview ...  |  read more...
USD 2,000
Analgesics in India
6/15/2015 | published by: Euromonitor International
... disorders, consumers continued to move extensively towards analgesics which helped them to find temporary relief from pain without visiting a doctor. Euromonitor International's Analgesics in India report offers a comprehensive guide to the size and ...  |  read more...
USD 990
Analgesics in New Zealand
6/15/2015 | published by: Euromonitor International
... up from 59% in 2010. This increase of seven percentage points in sales via supermarkets seen over the last four years was predominantly due to the cheaper prices offered by this retail channel, and due ...  |  read more...
USD 990
Analgesics in Romania
6/17/2015 | published by: Euromonitor International
... in 2014. The 11% rise in the sales of combination products boosted the performance of the overall category and compensated for the 17% decline in sales of dipyrone. The switch of dipyrone/metamizole to RX medication ...  |  read more...
USD 990
Calming and Sleeping in Romania
6/17/2015 | published by: Euromonitor International
... sleeping products. The majority of standard calming and sleeping products are thus sold only as Rx drugs. Nevertheless, category sales experienced stable growth, after rising by 10% in 2014, due to the growing preference for ...  |  read more...
USD 990
Calming and Sleeping in South Korea
6/19/2015 | published by: Euromonitor International
... leading brand in herbal/traditional calming products, Woo Hwang Chung Sim Won, saw current value growth of 18% in 2014. Euromonitor International's Calming and Sleeping in South Korea report offers a comprehensive guide to the size ...  |  read more...
USD 990
Cough, Cold and Allergy (Hay Fever) Remedies in Australia
6/15/2015 | published by: Euromonitor International
... this improved performance included a slightly cooler winter and more erratic weather conditions in Australia as compared to 2013, and the growing number of consumers affected by allergic rhinitis, also known as hay fever. Euromonitor ...  |  read more...
USD 990
Cough, Cold and Allergy (Hay Fever) Remedies in Romania
6/17/2015 | published by: Euromonitor International
... to the dynamic growth in antihistamines/allergy remedies, sales of which hiked by 14% in 2014, and the significant 12% rise in paediatric cough, cold and allergy remedies. Increasingly stressful lifestyles, weaker immune systems and increasing ...  |  read more...
USD 990
Dermatologicals in India
6/15/2015 | published by: Euromonitor International
... In addition, greater awareness of skin care led many consumers to opt for buying over-the-counter products from chemists/pharmacies. Euromonitor International's Dermatologicals in India report offers a comprehensive guide to the size and shape of the ...  |  read more...
USD 990
Dermatologicals in Romania
6/17/2015 | published by: Euromonitor International
... treatment, nappy rash treatment, cold sore treatment and recently also in haemorrhoid treatments, which explains the high sales growth of the aforementioned OTC categories. Hair problems, nappy rash and haemorrhoids are common problems among consumers, ...  |  read more...
USD 990
Dermatologicals in South Korea
6/19/2015 | published by: Euromonitor International
... marketing activities and the good performance in grocery retailers such as hypermarkets and convenience stores. Topical germicidals/antiseptics decreased by -1% in 2013 as hydrate tape included under gauze, tape and other wound care increased rapidly. ...  |  read more...
USD 990
< prev 1    3  4  5  6  7  8  9  10